These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8523425

  • 1. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning.
    Jenkins DP, Pugsley WB, Yellon DM.
    J Mol Cell Cardiol; 1995 Aug; 27(8):1623-32. PubMed ID: 8523425
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of preconditioning on post-ischaemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts.
    Efstathiou A, Seraskeris S, Papakonstantinou C, Aidonopoulos A, Lazou A.
    Eur J Cardiothorac Surg; 2001 Apr; 19(4):493-9. PubMed ID: 11306319
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models.
    Sandhu R, Diaz RJ, Wilson GJ.
    Cardiovasc Res; 1993 Apr; 27(4):602-7. PubMed ID: 8324793
    [Abstract] [Full Text] [Related]

  • 4. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
    Lochner A, Genade S, Moolman JA.
    Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
    [Abstract] [Full Text] [Related]

  • 5. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M, Catena TG, Vander Heide RS, Jennings RB, Reimer KA.
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 7. Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium.
    Sumeray MS, Yellon DM.
    Basic Res Cardiol; 1998 Oct; 93(5):384-90. PubMed ID: 9833150
    [Abstract] [Full Text] [Related]

  • 8. Manipulations in glycogen metabolism and the failure to influence infarct size in the ischaemic rabbit heart.
    Gozal Y, Wolff RA, Van Winkle DM.
    Eur J Anaesthesiol; 2002 Jul; 19(7):495-503. PubMed ID: 12113612
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart--a protective additive to ischaemic preconditioning.
    Bugge E, Ytrehus K.
    Cardiovasc Res; 1995 Feb; 29(2):269-74. PubMed ID: 7736505
    [Abstract] [Full Text] [Related]

  • 10. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning.
    Gelpi RJ, Morales C, Cohen MV, Downey JM.
    Basic Res Cardiol; 2002 Jan; 97(1):40-6. PubMed ID: 11998976
    [Abstract] [Full Text] [Related]

  • 11. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.
    Toombs CF, Moore TL, Shebuski RJ.
    Cardiovasc Res; 1993 Apr; 27(4):617-22. PubMed ID: 8324795
    [Abstract] [Full Text] [Related]

  • 12. Preconditioning improves myocardial function and reflow, but not vasodilator reactivity, after ischaemia and reperfusion in anaesthetized dogs.
    Loke KE, Woodman OL.
    Clin Exp Pharmacol Physiol; 1998 Apr; 25(7-8):552-8. PubMed ID: 9673427
    [Abstract] [Full Text] [Related]

  • 13. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
    McCully JD, Uematsu M, Parker RA, Levitsky S.
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
    [Abstract] [Full Text] [Related]

  • 14. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.
    Imagawa J, Baxter GF, Yellon DM.
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):74-9. PubMed ID: 9456280
    [Abstract] [Full Text] [Related]

  • 15. The protection of ischaemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned.
    Yang XM, Arnoult S, Tsuchida A, Cope D, Thornton JD, Daly JF, Cohen MV, Downey JM.
    Cardiovasc Res; 1993 Apr; 27(4):556-8. PubMed ID: 8324785
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):115-20. PubMed ID: 17157294
    [Abstract] [Full Text] [Related]

  • 17. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts.
    Suematsu Y, Ohtsuka T, Hirata Y, Maeda K, Imanaka K, Takamoto S.
    Eur J Cardiothorac Surg; 2001 Jun 05; 19(6):873-9. PubMed ID: 11404145
    [Abstract] [Full Text] [Related]

  • 18. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia.
    Cave AC, Hearse DJ.
    J Mol Cell Cardiol; 1992 Oct 05; 24(10):1113-23. PubMed ID: 1479613
    [Abstract] [Full Text] [Related]

  • 19. Global myocardial ischemia protects the myocardium from subsequent regional ischemia.
    Walker DM, Walker JM, Yellon DM.
    Cardioscience; 1993 Dec 05; 4(4):263-6. PubMed ID: 8298068
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.